Remove Confidentiality Remove Patent Application Remove Patent Prosecution Remove Trademark
article thumbnail

Cloaked in Secrecy: Can Secrecy Orders Shield Alien Innovations?

LexBlog IP

In a recent post , we discussed whether patent applications could provide insight into the blueprints of extraterrestrial spacecraft. Yet, an enigmatic question looms large: would the powers that be genuinely consider patenting such advanced technology, fully aware that patent applications might see the light of day?

article thumbnail

Cloaked in Secrecy: Can Secrecy Orders Shield Alien Innovations?

LexBlog IP

In a recent post , we discussed whether patent applications could provide insight into the blueprints of extraterrestrial spacecraft. Yet, an enigmatic question looms large: would the powers that be genuinely consider patenting such advanced technology, fully aware that patent applications might see the light of day?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cloaked in Secrecy: Can Secrecy Orders Shield Alien Innovations?

Trading Secrets

In a recent post , we discussed whether patent applications could provide insight into the blueprints of extraterrestrial spacecraft. Yet, an enigmatic question looms large: would the powers that be genuinely consider patenting such advanced technology, fully aware that patent applications might see the light of day?

article thumbnail

Taking Another Page from the ABA: The USPTO Enacts New Rules of Professional Responsibility for Patent Attorneys and Agents

IP Tech Blog

To mitigate potential conflicts of interest and to improve the public’s understanding of the United States Patent and Trademark Office (USPTO) procedures, the agency has recently made various amendments to its rules relating to the conduct of registered patent attorneys and agents.

article thumbnail

What to Know About the USPTO’s Duty of Candor Guidance Regarding FDA Submissions

Fish & Richardson Trademark & Copyright Thoughts

In view of this notice, life sciences companies should consider involving patent counsel in the review of relevant FDA submissions for possible inconsistencies with PTO filings and determination of the appropriate course of action where material inconsistencies are found to exist. Preserving confidentiality and privilege.

article thumbnail

Journey Through “Septembers” on SpicyIP (2005 – Present)

SpicyIP

Coming back to NIA, among other things , the NIA Act also became known for its objective to codify and consolidate the law of confidentiality and trade secrets – something for which there is no specific law in India. In fact, the Registry used to generate a sum of around 4 crores INR , from trademark searches before embracing public access.

article thumbnail

Spicy IP Weekly Review (December 11 to December 17)

SpicyIP

From conflicting positions on AI as a co-author of a work to the contours of information required u/s 39 about the patent applications filed abroad, we had some engaging posts on this blog this week. Read this post by SpicyIP intern Jyotpreet on what this means for the delays in patent prosecution timelines.

IP 59